Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
329.8500 1.70 (0.52%)
NSE May 13, 2025 15:31 PM
Volume: 4.5M
 

announcement
Conference/Earnings Calls Alerts
logo
Biocon Ltd.
17 Sep 2021
329.85
0.52%

Conference Call with Management from Biocon (Kiran Mazumdar Shaw) and Serum Institute (Adar Poonawalla) on the strategic alliance between Biocon Biologics and Serum Institute subsidiary Covidshield Technologies. Listen to the full transcript.

More from Biocon Ltd.
All earning calls
Investor presentations from Biocon Ltd.
All investor presentations